deferoxamine has been researched along with Bone Marrow Diseases in 5 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Bone Marrow Diseases: Diseases involving the BONE MARROW.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thio, D | 1 |
| Prasad, V | 1 |
| Anslow, P | 1 |
| Lennox, P | 1 |
| Jensen, PD | 1 |
| Heickendorff, L | 1 |
| Pedersen, B | 1 |
| Bendix-Hansen, K | 1 |
| Jensen, FT | 1 |
| Christensen, T | 1 |
| Boesen, AM | 1 |
| Ellegaard, J | 1 |
| Donfrancesco, A | 1 |
| Deb, G | 1 |
| Dominici, C | 1 |
| Angioni, A | 1 |
| Caniglia, M | 1 |
| De Sio, L | 1 |
| Fidani, P | 1 |
| Amici, A | 1 |
| Helson, L | 1 |
| Turnbull, A | 1 |
| Burg, G | 1 |
1 review available for deferoxamine and Bone Marrow Diseases
| Article | Year |
|---|---|
Iron metabolism in the porphyrias.
Topics: Alcohol Drinking; Amino Acids; Anemia, Hemolytic; Bloodletting; Bone Marrow; Bone Marrow Diseases; D | 1971 |
4 other studies available for deferoxamine and Bone Marrow Diseases
| Article | Year |
|---|---|
Marrow proliferation as a cause of hearing loss in beta-thalassaemia major.
Topics: beta-Thalassemia; Bone Marrow Diseases; Child; Deferoxamine; Hearing Loss; Humans; Male; Siderophore | 2008 |
The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload.
Topics: Adolescent; Aged; Bone Marrow Diseases; Chromosome Aberrations; Deferoxamine; Erythropoietin; Female | 1996 |
Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Chelation Therapy | 1992 |
[Therapy of porphyrias].
Topics: Acute Disease; Bone Marrow Diseases; Chlorpromazine; Deferoxamine; Erythropoiesis; Humans; Phospholi | 1972 |